Intracameral bevacizumab (Avastin ®) in the management of neovascular glaucoma surgery;Bevacizumab (Avastin ®) intracamerular en el manejo quirúrgico del glaucoma neovascular

Archivos de la Sociedad Espanola de Oftalmologia

Volumn 87, Issue 12, 2012, Pages 396-400

  Fernandez Jimenez Ortiz, H ^a   Perucho Martinez, S ^a   Toledano Fernandez N ^a   Martin Giral, E ^a  

^a HOSPITAL UNIVERSITARIO DE FUENLABRADA   (Spain)

Author keywords

Angiogenesis inhibitors; Bevacizumab; Filtering surgery; Glaucoma neovascular; Injections intraocular

Indexed keywords

BEVACIZUMAB; MONOCLONAL ANTIBODY; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; ARTICLE; DIABETIC RETINOPATHY; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; FEMALE; FILTERING OPERATION; HUMAN; INTRAOCULAR DRUG ADMINISTRATION; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOVASCULAR GLAUCOMA; POSTOPERATIVE HEMORRHAGE; RETINA HEMORRHAGE; RETROSPECTIVE STUDY; VERY ELDERLY;

ADULT; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL, HUMANIZED; COMBINED MODALITY THERAPY; DIABETIC RETINOPATHY; DRUG EVALUATION; FEMALE; FILTERING SURGERY; GLAUCOMA, NEOVASCULAR; HUMANS; INJECTIONS, INTRAOCULAR; INTRAOCULAR PRESSURE; LIGHT COAGULATION; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; RETINAL HEMORRHAGE; RETROSPECTIVE STUDIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84868201070     PISSN: 03656691     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oftal.2011.09.025     Document Type: Article

References (21)

1. K.D. Miller, L.I. Chap, F.A. Holmes, M.A. Cobleigh, P.K. Marcom, and L. Fehrenbacher Randomized phase III trial of capecitabine compared with bevacizumab plus J Clin Oncol 23 2005 792 799
2. P.J. Hudson, and C. Souriau Engineered antibodies Nat Med 9 2003 129 134
3. R.C. Tripathi, J. Li, B.J. Tripathi, K.V. Chalam, and A.P. Adamis Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma Ophthalmology 105 1998 232 237
4. J.O. Mason 3rd, M.A. Albert Jr., A. Mays, and R. Vail Regression of neovascular iris vessels by intravitreal injection of bevacizumab Retina 26 2006 839 841
5. J.B. Jonas, U.H. Spandau, and F. Schlichtenbrede Intravitreal bevacizumab for filtering surgery Ophthalmic Res 39 2007 121 122
6. C.M. Andreoli, and J.W. Miller Anti-vascular endothelial growth factor therapy for ocular neovascular disease Curr Opin Ophthalmol 18 2007 502 508
7. S. Yazdani, K. Hendi, and M. Pakravan Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma J Glaucoma 16 2007 437 439
8. A. Kotecha, A. Spratt, L. Ogunbowale, R. Dell'Omo, A. Kulkarni, and C. Bunce Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series Arch Ophthalmol 129 2011 145 150
9. J.Y. Cheng, D.W. Wong, and C.L. Ang Intraocular avastin (bevacizumab) for neovascularisation of the iris and neovascular glaucoma Ann Acad Med Singapore 37 2008 72 74
10. M.E. Gheith, G.A. Siam, D.S. de Barros, S.J. Garg, and M.R. Moster Role of intravitreal bevacizumab in neovascular glaucoma J Ocul Pharmacol 23 2007 487 491
11. S. Grisanti, S. Biester, S. Peters, O. Tatar, F. Ziemssen, and K.U. Bartz-Schmidt Intracameral bevacizumab for iris rubeosis Am J Ophthalmol 142 2006 158 160
12. P. Ichhpujani, A. Ramasubramanian, S. Kaushik, and S.S. Pandav Bevacizumab in glaucoma: a review Can J Ophthalmol 42 2007 812 815
13. T. Wakabayashi, Y. Oshima, H. Sakaguchi, Y. Ikuno, A. Miki, and F. Gomi Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases Ophthalmology 115 2008 1571 1580
14. S. Duch, O. Buchacra, E. Milla, D. Andreu, and J. Tellez Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients J Glaucoma 18 2009 140 143
15. C.H. Chen, I.C. Lai, P.C. Wu, Y.J. Chen, Y.H. Chen, and J.J. Lee Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma J Ocul Pharmacol Ther 26 2010 111 118
16. F.J. Montañez, E. Laso, M. Suñer, and C. Amaya Implante de válvula de Ahmed. Nuestra experiencia 1995-2003 Arch Soc Esp Oftalmol 80 2005 239 244
17. J.K. Luttrull, and R.L. Avery Pars plana implant and vitrectomy for treatment of neovascular glaucoma Retina 15 1995 379 387
18. M.A. Siddiqui, and G.M. Keating Pegaptanib: in exudative age-related macular degeneration Drugs 65 2005 1571 1577 discussion 1578-1579
19. D.J. D'Amico, H.N. Masonson, M. Patel, A.P. Adamis, and E.T. Cunningham Jr. Pegaptanib sodium for neovascular age-related macular degeneration: two-year safety results of the two prospective, multicenter, controlled clinical trials. VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial Group Ophthalmology 113 2006 992 1001
20. S. Ghosh, D. Singh, J.B. Ruddle, M. Shiu, M.A. Coote, and J.G. Crowston Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma Clin Experiment Ophthalmol 38 2010 353 357
21. Y. Saito, T. Higashide, H. Takeda, E. Murotani, S. Ohkubo, and K. Sugiyama Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab Am J Ophthalmol 149 2010 964 972